Improving Therapeutic Adherence of Adult Patients With Cystic Fibrosis: Impact of a Co-constructed Program by Patients and Health Caregivers.
Improving Therapeutic Adherence of Adult Patients With Cystic Fibrosis: Impact of a Co-constructed Program by Patients and Health Caregivers.
Background Cystic fibrosis is a life-threatening genetic disorder responsible for pulmonary failure and multi-systemic complications involving specific and large medical care burden. To date, no program has shown its effectiveness in improving therapeutic adherence. A new approach to develop a co-constructed program involving patients and professionals may contribute to improve therapeutic adherence.
Objectives The aim of the MUCOBS-Trial project is to create a program to increase therapeutic adherence and to evaluate its efficacy in adult patients with cystic fibrosis in 3 CF centers in France.
Inclusion Criteria:
Exclusion Criteria:
Quitterie.reynaud@chu-lyon.fr4 78 86 13 56 ext. +33
marie.viprey@chu-lyon.fr4 72 11 51 62 ext. +33
Clermont-Ferrand, 63100, France
quitterie.reynaud@chu-lyon.fr
marie.viprey@chu-lyon.fr